# Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)

> clinical trial · VERIFIED · 2026-07-16

Status: ACTIVE_NOT_RECRUITING · Sponsor: Genentech, Inc. · Condition: Spinal Muscular Atrophy

- Company: Genentech, Inc.
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT05232929

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.